Summary Natural and lymphokine activated killer cells (NK and LAK) 
Natural killer (NK) cells are a phenotypically heterogeneous effector subpopulation of lymphocytes, with large azurophilic granules in their cytoplasm. NK cells display a spontaneous cytotoxicity against a variety of tumour cells (Herberman, 1986) , virus infected cells and some normal cells in bone marrow and thymus. In vitro NK activity can be measured against K562 cells, classical targets which lack class I and class II MHC gene products on their surface (Ythier & Hercend, 1986) . Interferons, TNF-a and IL-2 are potent inducers of NK activity (Itoh et al., 1985; Ostensen et al., 1987; Burns et al., 1985) .
Lymphocyte activated killer (LAK) cells obtained after 3-5 days of culture of PBL in the presence of 2-3 ng ml-' IL-2, are able to kill a wide variety of established cell lines, autologous and allogeneic fresh tumour cells and cells which are resistant to NK cytolysis (Grimm et al., 1982) .
NK and LAK cells are believed to play an important role in the control of tumour progression and metastasis. They are distinct from immune cytotoxic T lymphocytes, since they are spontaneously lytic to target cells lacking MHC gene products. Their specific receptors for tumours cells are still unknown and probably distinct from the T cell receptor (Herberman, 1986) . Several studies suggest that these cells recognize and eliminate abnormal cells with deleted or reduced expression of MHC class I molecules (Storkus et al., 1987) . Previous reports suggest that a and y interferons, by increasing MHC class I expression in target cells, induce resistance to killing by NK cells (Taniguchi et al., 1987) . In this paper we report the effect of gamma interferon on MHC class I and II expression in two human breast cancer cell lines and upon their susceptibility to killing by NK and LAK cells. We, thus, tested the role of HLA class I and II in tumour cells cytolysis.
Materials and methods

Reagents
Purified human recombinant gamma interferon with specific activity of 2 x 107 U mg-' protein, was kindly provided by Dr M. Brandely (Roussel Uclaf Laboratories).
Highly purified human interleukin-2 prepared from normal peripheral blood cell cultures (Banque du Sang, H6pital Saint Louis) was used at a final concentration of 2.7 ng ml-'. In some experiments, recombinant human IL-2 from Roussel-Uclaf was also used and gave comparable results.
Target cells
Two metastatic human breast adenocarcinoma cell lines were tested: T47D (Keydar et al., 1979) and ZR75-1 (Engel et al., 1978) . Both cell lines were cultured in DMEM (Gibco) supplemented with 10% heat inactivated fetal calf serum, 2 mM L-glutamine.
Monoclonal antibodies (MoAb) MoAb M28 is an IgG2a which recognises 02 microglobin (O2M) at the cell surface (Fellous et al., 1981) . MoAb W6-32 (IgG2a) recognises a framework determinant of HLA A,B,C heavy chain (Barnstable et al., 1978) . MoAb D1-12 (IgG2a) is an anti-HLA class II directed to a monomorphic determinant of DR locus (Carrel et al., 1981) . MoAb H6F3 is directed against transferrin receptor. These antibodies were used as ascitic fluids or as purified F(ab')2 fragments. F(ab')2 fragments were isolated, after digestion of the antibodies with pepsin, by chromatography on protein A. Indirect immunofluorescence was then performed with the F(ab')2 fragments on T47D and ZR75-1 cell lines, analysed using flow cytometry Laemmli (1970) and adapted by O'Farrel (1975) and O'Farrel et al. (1977) . In the first dimension, the proteins were separated according to their charges using a non equilibrium pH gradient electrophoresis (NEPHGE). The second dimension was run in 10% acrylamide slab gel (Charron & McDevitt, 1980 2D gel electrophoresis Biosynthesis of HLA molecules was studied in the two cell lines (Figure 1 ). 2D gel analysis of HLA class I molecules in untreated cells presented a complex pattern including a set of spots at 44 kDa corresponding to the heavy chain(s) and one spot at 12 kDa corresponding to P2M. IFN-y treatment induced an increase in biosynthesis of these molecules.
Before treatment, immunoprecipitation using Dl-12 MoAb failed to show any spot in the molecular weight range corresponding to HLA DR.
After IFN-1 treatment (1,000 U ml-', 48 h), 2D gel analysis revealed the classical profile of human heterodimeric molecules including an acidic a chain of 32-34 kDa, a more basic 27-29 P chain and a 31 kDa molecule corresponding to the invariant chain (Ii).
NK activity
The susceptibility of untreated and IFN-y treated breast cancer cells to non-MHC restricted cytotoxicity were compared. Their susceptibility to NK lysis was first tested, using, as effector cells, freshly separated normal human lymphocytes in a 4 h chromium release assay. As shown in Figure 2 , 40% of either T47D (panel a) or ZR75-1 (panel b) cells were lysed by normal PBL at a 200:1 effector to target cell ratio. IFN-y treated cells were poorly lysed at this high a dilution. Similar results with small variations of lysis intensity were observed independent of the blood donor (not shown).
LAK activity
The activated IL-2 cells were used as effectors in a 4 h chromium release assay at a maximum effector-to-target ratio of 25:1. As shown in Figure 2 , untreated breast cancer cells were more susceptible to LAK lysis than IFN-'y treated cells.
This result was found with the two cell lines tested, T47D (panel c) and ZR75-1 (panel d). Several experiments with other effector cell-donors have given identical results (not shown).
Modulation of target lysis by anti-HLA class I antibody
To test whether induction of HLA class I molecules was responsible for resistance to the non MHC restricted cytotoxicity, the ability to restore lysis by masking these molecules As shown in Figure 3 the F(ab')2 fragments from neither W6-32 or the control antibodies restored the susceptibility to lysis of IFN-y treated cells to NK and LAK effectors (T47D panels a and c, ZR75-1 panels b and d).
Similar experiments using complete antibodies gave very different results. All the antibodies tested increased the lysis of IFN-y treated breast cancer cells to both NK and LAK mediated cytotoxicity (Figure 2 ). The previous results were obtained either by preincubating target cells with antibodies or by the addition of antibodies during the 4 h microcytotoxicity assay.
Discussion
We report data on two metastatic human breast carcinoma cell lines which spontaneously express low levels of HLA class I molecules and do not express HLA class II. These two cell lines are NK and LAK sensitive. Pretreatment of these two target cells with IFN-y induced a dramatic increase of HLA class I expression and de novo membrane expression of HLA class II molecules. This synthesis was studied at membrane and protein levels. IFN-y treatment induced an increased resistance of target cells to NK and LAK lysis.
The molecular mechanisms of target recognition and lysis by the non-MHC restricted cytotoxic effector cells remain controversial. Previous results in animal (Karre et al., 1986) and human (Storkus et al., 1987; Harel-Bellan et al., 1986) (Dalianis et al., 1981) .
In our system IFN-y provoked an increase of HLA class I expression at the surface of the breast cancer cells which was associated with a decreased susceptibility to NK and LAK cytolysis.
Nevertheless, masking the HLA class I determinants with F(ab')2 fragments failed to modify the resistance induced by IFN-y treatment, indicating that the increased HLA class I expression is probably not directly responsible for NK and LAK target recognition. This effect on susceptibility to lysis could be related to effects on target molecules other than MHC, since IFN--y is known to both stimulate and decrease the synthesis of several proteins specifically (Adolf, 1985) . It has also been suggested that NK cells in man interact with the transferrin receptor on tumour cells (Alarcon & Ferrat, 1985) and that mouse NK cells recognise the laminin receptor on their targets, appearing to have a laminin-like substance on their surface (Hiserodt et al., 1985) . IFN-y has been recently shown to modulate tumour necrosis factor receptor expression on epithelial cancer cells (Aggarwal et al., 1985) . However, the effect of IFN may be indirectly related to HLA modulation. A very attractive hypothesis would be that HLA class I molecules are in close association with NK or LAK target structures. This hypothesis is substantiated by a number of reports which indicated that several molecules are associated with HLA class I at the cell surface, including the insulin receptor (Chvatchko et al., 1983) , the IL-2 receptor (Szollosi et al., 1987) and the EGF receptor (Schreiber et al., 1984) , and are modulated by IFN-y (Pfeffer et al., 1987; Zoon et al., 1986) .
The intact IgG molecules of the same monoclonal anti- bearing patients and ADCC could be a component of an interleukin-2 LAK-based treatment strategy (Herberman et al., 1979 
